Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The CER6-GL2 enzyme complex is a critical heteromeric assembly in plants, primarily responsible for the biosynthesis of very-long-chain fatty acids (VLCFAs) with chain lengths exceeding 28 carbons. It consists of the core catalytic subunit 3-ketoacyl-CoA synthase 6 (CER6 or KCS6) and a non-catalytic BAHD family protein known as Glossy2 (GL2) in maize or CER2 in Arabidopsis. While CER6 possesses the enzymatic machinery—a Cys-His-Asn catalytic triad—it is unable to produce fatty acids longer than C28 on its own. The GL2 subunit binds to CER6 to structurally remodel and expand the enzyme's substrate-binding tunnel into a continuous hydrophobic channel, enabling the elongation of acyl chains up to C34. This complex serves as a vital target in agricultural biotechnology for the development of stress-resilient crops. By modulating the activity of the CER6-GL2 complex, researchers can alter the deposition and composition of plant cuticular wax, which acts as the primary barrier against non-stomatal water loss and pathogen invasion. Recent structural studies using cryo-electron microscopy have elucidated the heterotetrameric stoichiometry of the complex, providing a molecular blueprint for engineering plants with enhanced drought tolerance and environmental adaptability. While not a target for human therapeutics, it remains a focal point for the development of novel agrochemicals and genetic traits intended to secure global food supplies under changing climatic conditions.
The complex catalyzes the condensation of malonyl-CoA with acyl-CoA to elongate fatty acid chains; specifically, GL2/CER2 acts as a non-catalytic subunit that remodels the substrate tunnel of CER6 to facilitate elongation beyond C28 to C34.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 3-ketoacyl-CoA synthase 6-Glossy2 enzyme complex (CER6-GL2).